Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment [clinicaltrials_resource:47a5b7f7b38f7398eaa34bd903356493]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment [clinicaltrials_resource:47a5b7f7b38f7398eaa34bd903356493]
Bio2RDF identifier
47a5b7f7b38f7398eaa34bd903356493
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:47a5b7f7b38f7398eaa34bd903356493
measure [clinicaltrials_vocabulary:measure]
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment
identifier
clinicaltrials_resource:47a5b7f7b38f7398eaa34bd903356493
title
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment
@en
type
label
Safety of vildagliptin in comb ...... 5b7f7b38f7398eaa34bd903356493]
@en